Models of the impact of dengue vaccines: A review of current research and potential approaches

被引:73
|
作者
Johansson, Michael A. [2 ]
Hombach, Joachim [3 ]
Cummings, Derek A. T. [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] US Ctr Dis Control, Div Vector Borne Dis, San Juan, PR 00920 USA
[3] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland
基金
美国国家卫生研究院;
关键词
Diff46Dengue; Vaccine; Theoretical model; Review; ANTIBODY-DEPENDENT ENHANCEMENT; SAO-PAULO STATE; HEMORRHAGIC-FEVER; TRANSMISSION DYNAMICS; REPRODUCTION NUMBER; VIRUS SEROTYPES; DISEASE-MODELS; BORNE DISEASES; YELLOW-FEVER; EPIDEMIC;
D O I
10.1016/j.vaccine.2011.06.042
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination reduces transmission of pathogens directly, by preventing individual infections, and indirectly, by reducing the probability of contact between infected individuals and susceptible ones. The potential combined impact of future dengue vaccines can be estimated using mathematical models of transmission. However, there is considerable uncertainty in the structure of models that accurately represent dengue transmission dynamics. Here, we review models that could be used to assess the impact of future dengue immunization programmes. We also review approaches that have been used to validate and parameterize models. A key parameter of all approaches is the basic reproduction number, R-0, which can be used to determine the critical vaccination fraction to eliminate transmission. We review several methods that have been used to estimate this quantity. Finally, we discuss the characteristics of dengue vaccines that must be estimated to accurately assess their potential impact on dengue virus transmission. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5860 / 5868
页数:9
相关论文
共 50 条
  • [1] Vaccines against dengue: a review of current candidate vaccines at advanced development stages
    Hombach, Joachim
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2007, 21 (04): : 254 - 260
  • [2] Current progress in dengue vaccines
    Wan, Shu-Wen
    Lin, Chiou-Feng
    Wang, Shuying
    Chen, Yu-Hung
    Yeh, Trai-Ming
    Liu, Hsiao-Sheng
    Anderson, Robert
    Lin, Yee-Shin
    JOURNAL OF BIOMEDICAL SCIENCE, 2013, 20
  • [3] Current progress in dengue vaccines
    Shu-Wen Wan
    Chiou-Feng Lin
    Shuying Wang
    Yu-Hung Chen
    Trai-Ming Yeh
    Hsiao-Sheng Liu
    Robert Anderson
    Yee-Shin Lin
    Journal of Biomedical Science, 20
  • [4] CURRENT APPROACHES TO THE DEVELOPMENT OF DENGUE VACCINES AND RELATED ASPECTS OF THE MOLECULAR-BIOLOGY OF FLAVIVIRUSES
    BRANDT, WE
    JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05): : 1105 - 1111
  • [5] Current status of the development of dengue vaccines
    Lee, Michelle Felicia
    Long, Chiau Ming
    Poh, Chit Laa
    VACCINE: X, 2025, 22
  • [6] Dengue vaccines: the current clinical perspective
    Goh, Daniel Y. T.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S17 - S17
  • [7] Mouse models for dengue vaccines and antivirals
    Plummer, Emily M.
    Shresta, Sujan
    JOURNAL OF IMMUNOLOGICAL METHODS, 2014, 410 : 34 - 38
  • [8] Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
    Stylianou, Elena
    Paul, Matthew J.
    Reljic, Rajko
    McShane, Helen
    EXPERT REVIEW OF VACCINES, 2019, 18 (12) : 1271 - 1284
  • [9] A search for vaccines and therapeutic for dengue: A review
    Wahab, Habibah A.
    Yusof, Rohana
    Rahman, Noorsaadah A.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (02) : 101 - 112
  • [10] Dengue Vaccines: Current Status and Future Prospects
    Bharati, Kaushik
    Jain, Hemant
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (06) : AB1 - AB3